tiprankstipranks
Trending News
More News >
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Canadian Market

Eupraxia Pharmaceuticals (EPRX) Cash flow

Compare
45 Followers

Eupraxia Pharmaceuticals Cash Flow

TSE:EPRX's free cash flow for Q3 2025 was C$-4.57M. For the 2025 fiscal year, TSE:EPRX's free cash flow was decreased by C$-2.08M and operating cash flow was C$-4.51M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -29.99MC$ -27.92MC$ -18.78MC$ -14.64MC$ -403.93K
Investing Cash Flow
C$ -75.16KC$ -99.03KC$ 8.70MC$ -14.45MC$ 24.62K
Financing Cash Flow
C$ 45.78MC$ 27.84MC$ 13.52MC$ 49.92MC$ -626.64K
End Cash Position
C$ 33.10MC$ 19.34MC$ 24.74MC$ 20.89MC$ 150.13K
Free Cash Flow
C$ -30.10MC$ -28.02MC$ -19.08MC$ -15.07MC$ -403.93K
Currency in CAD

Eupraxia Pharmaceuticals Cash Flow